Search

Dermatoses are skin diseases caused by lowered level of lipids in the intercellular lipid matrix of skin’s uppermost layer stratum corneum. A promising therapy is the application of liposomally formulated skin lipids (ceramides, cholesterol, fatty acids). These so called cerosomes proved very effective in disrupted skin barrier repair; however, they aim primarily on a mechanical surface restoration. For this reason an interesting idea is to combine the cerosomes and anti-inflammatory drugs (such as hydrocortisone) used for the treatment of pathophysiological processes in the skin. Unfortunately, liposomes generally show low drug encapsulation rates, hence they would not be very effective carriers. On the other hand, great encapsulation effectivity can be found in lipid nanocapsules (LNCs). We therefore aimed to create a combined system cerosomes-LNCs that would ensure the skin barrier restoration thanks to the ceramides and simultaneously effectively deliver hydrocortisone as a representative of anti-inflammatory drugs into lower layers of the skin. In this work, we characterized the formulations by dynamic light scattering and transmission electron microscopy to assess their size and morphology., SPhERe Proceedings: 4th International Symposium on Pharmaceutical Engineering Research

Diseases related to a disrupted skin barrier are accompanied by lower levels of ceramides in the stratum corneum (SC) lipid matrix. Delivering ceramides directly into damaged skin is a viable alternative to conventional corticosteroids, but is hindered by their low skin bioavailability and limited nanoformulation ability. Here, we developed stable liposomal systems containing ceramides and other SC lipids, and tested their effectiveness in skin barrier repair. Lipid film hydration and high-pressure homogenization were used to prepare different types of liposomes. To determine the stability, the particle size and polydispersity index were measured. The optimal systems were found to include ceramide 3 and 6, cholesterol and stearic acid, with 10% urea in phosphate-buffered saline as the aqueous phase. The ability of the system to repair chemically-damaged porcine skin was tested. While treatment by a standard lipid suspension reduced the passage of a model permeant only to a limited extent, drug flux through the liposomally-treated skin was much closer to permeation through intact skin. The non-homogenized liposomes were more effective than their homogenized version. These findings were also confirmed by FTIR measurements. This suggests that our approach to liposomal development has considerable potential for the repair of a disrupted skin barrier.